Other Indications — Trokendi XR® For Certain Types Of Epilepsy

All commercially insured patients new to Trokendi XR pay nothing for a minimum of 12 prescriptions*—guaranteed.

*Click here for Terms and Conditions.

Trokendi XR is a once-daily topiramate

In addition to migraine prevention, Trokendi XR (topiramate) is indicated as initial monotherapy in patients 6 years of age and older with partial onset or primary generalized tonic-clonic seizures and as adjunctive therapy in patients 6 years of age and older with partial onset, primary generalized tonic-clonic seizures associated with Lennox-Gastaut syndrome.

In a conversion study, 93.4% of patients with epilepsy who had been taking a stable dose of immediate-release topiramate for a minimum of 1 month prior to study entry preferred Trokendi XR (topiramate)1

Conversion study where patients with epilepsy preferred Trokendi XR (topiramate)

Converting your patients to once-daily Trokendi XR (topiramate) is easy1

Example of same-day conversion for patients switching to once-a-day Trokendi XR (topiramate) from twice-daily Topamax (topiramate)1-3† Twice daily Topamax 100 mg equals once-daily Trokendi XR (topiramate) Tablets and capsule shown are not actual size. Recommended dose of Trokendi XR (topiramate) as adjunctive therapy in adults with partial onset seizures is 200 mg/day.

Dosage and administration for new patients starting Trokendi XR (topiramate)2

Dosage and administration for new patients starting Trokendi XR (topiramate)

Abbreviation: LGS, Lennox-Gastaut syndrome.

IMPORTANT SAFETY INFORMATION

CONTRAINDICATIONS

WARNINGS & PRECAUTIONS

DOSING GUIDELINES & CONSIDERATIONS

ADVERSE REACTIONS

 

INDICATION

Please refer to the full Prescribing Information and Medication Guide for additional important information on Trokendi XR.

Trokendi XR (topiramate) extended-release capsules

 

REFERENCES:

  1. Data on file. Supernus Pharmaceuticals, Inc., Rockville, MD.
  2. Trokendi XR [package insert]. Rockville, MD: Supernus Pharmaceuticals, Inc.; January 2018.
  3. Topamax [package insert]. Titusville, NJ: Janssen Pharmaceuticals, Inc.; June 2018.